A Randomized, Double-Blind, Single-Site Phase II 2-Arm Study to Compare the Safety and Preliminary Efficacy of Manualized MDMA-Assisted Therapy to Low Dose D-Amphetamine Assisted Therapy in Veterans For The Treatment of Moderate to Severe PTSD
This randomized, double-blind, single-site phase II 2-arm study will investigate the safety and preliminary efficacy of MDMA-assisted therapy compared with low dose d-amphetamine-assisted therapy on the severity of PTSD symptoms in participants aged 18 years and older with PTSD of at least moderate severity.
- Status
- recruiting
- Phase
- Phase 2
- Institution
- Stephen Robert Marder
- Principal investigator
- Stephen Marder, MD
- Start date
- 2025-03-01
- End date
- 2026-03-01
- Registry ID
- NCT05790239
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.